查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1840591

体外膜氧合（ECMO）市场按设备类型、组件类型、患者类型、应用和最终用户划分－2025-2032年全球预测

Extracorporeal Membrane Oxygenation Machine Market by Device Type, Component Type, Patient Type, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，体外膜氧合市场规模将达到 8.4014 亿美元，复合年增长率为 5.40%。

主要市场统计数据
基准年 2024 5.5119亿美元
预计年份：2025年 5.7925亿美元
预测年份：2032年 8.4014亿美元
复合年增长率 (%) 5.40%

权威机构对体外氧气疗法）作为一种成熟的高级支持方式的认识，再形成重症加护路径和采购重点。

体外膜氧合（ECMO）已逐渐被临床接受，设备工程的不断改进使其从一种小众的抢救疗法转变为高级重症加护监护中不可或缺的选择。临床医生现在将体外支持视为一种过渡疗法，可以在患者经历急性呼吸或心臟危机时稳定其病情，同时寻求根治性治疗或器官移植。因此，医疗系统和临床团队正在调整通讯协定，组成多学科ECMO团队，并增加对训练和模拟的投入，以确保安全地部署和撤机。

随着技术创新者降低了设备复杂性并提高了迴路的生物相容性，体外膜氧合（ECMO）在传统加护病房之外的应用潜力日益增强。同时，监管审查和报销机制的动态既限制了ECMO的广泛应用，也带来了机会。因此，采购、临床指导和设备製造等相关人员在重新调整优先事项，以平衡临床疗效、运作准备和采购灵活性。 ECMO的广泛应用使其成为快速成熟的临床选择，对治疗路径、供应商关係和医院资源规划都有重大影响。

技术创新、营运模式重组和区域化医疗网络如何改变体外治疗的提供方式和医护人员关係

除了设备升级之外，体外膜氧气疗法（ECMO）领域正受到多项因素的共同再形成，这些因素正在重塑临床工作流程、供应链和服务模式。帮浦技术、呼吸器效率和表面涂层的进步正在减少溶血和血栓併发症，从而实现更持久、更安全的治疗。同时，双腔插管策略和经皮途径的兴起正在缩短部署时间并提高支援的便携性，从而能够在急救现场或转运过程中更快地启动治疗。

在营运方面，医院正将体外膜氧合（ECMO）纳入心胸外科和肺科诊疗流程，并加强常规训练和模拟，以确保医护人员能够应对体外心肺復苏术的各种情况。远端医疗和远端监测工具正将专家监测扩展到规模较小的医疗中心，从而更有效地利用区域支援网路和集中式专家资源。在商业方面，製造商正在整合数位化诊断、即插即用的抛弃式以及强调执行时间和生命週期管理的售后服务合约。总而言之，这些变革性因素正推动ECMO在临床应用方面取得进步，降低手术风险，并使设备性能与操作流程更加紧密地结合。

由于2025年关税调整，体外循环系统供应链的韧性和采购弹性受到挑战，这迫使企业重新评估筹资策略和零件在地化方案。

2025年美国关税调整为体外膜氧合（ECMO）系统的设备采购、零件采购和供应链弹性带来了新的动态。部分医疗零件和子组件的进口关税凸显了筹资策略的重要性，促使设备製造商和医院重新评估其供应商布局、零件本地化和库存政策。为此，一些製造商加快了对替代供应商的资格认证，并建立了多元化的物流管道，以降低对单一国家采购的依赖。

关税带来的成本压力促使人们更加关注供应链韧性的设计，包括模组化系统结构，这种架构允许在不影响临床性能的前提下，用本地可用的组件进行替换。医疗系统正日益重视资本采购、耗材和服务合约的总落地成本，并考虑签订多年期合约以稳定价格和供应。此外，关税促使製造商和监管机构展开对话，鼓励尽可能加快国内生产核准审批，并强化在区域中心策略性储备关键耗材的必要性。最终，2025年的关税环境凸显了采购弹性以及临床、监管和供应链各部门密切合作的必要性。

深入分析揭示了设备类型、组件特性、患者群体、临床应用和最终用户环境如何影响策略重点。

市场区隔分析揭示了不同设备类型、组件、患者群体、临床应用和终端用户环境之间的差异化动态，这些差异共同指导产品策略和市场推广策略。依设备类型划分，此细分市场可分为两类：一类是针对心臟支持的静脉-动脉系统，另一类是针对呼吸支持和体外氧合定制的静脉-静脉系统。按组件类型划分，该生态系统由插管、控制器、热交换器、氧合器和泵浦组成，每种组件都面临各自独特的工程挑战和售后市场考量。依患者类型划分，成人、婴幼儿和儿童患者的临床需求各不相同，因此需要针对不同尺寸的插管技术、流量曲线和监测功能。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 整合人工智慧演算法进行即时体外膜氧合（ECMO）迴路参数优化
  • 可携式、便携性膜氧合（ECMO）系统的出现，使得在现场进行挽救生命的干预成为可能。
  • 开发生物相容性聚合物涂层以减轻长期体外膜氧合（ECMO）支持应用中的血栓症
  • 扩大静脉-动脉体外膜氧合（VA-ECMO）和移动式体外膜氧合（ECMO）团队在成人心源性休克治疗的应用
  • 低阻力中空纤维氧合器在改善新生儿和儿童体外膜氧合（ECMO）疗效方面的进展
  • 监管部门的核准加速了微型体外生命支持设备在门诊环境中的应用。
  • 医疗设备和软体公司合作开发整合式体外膜氧合（ECMO）数位监测平台

第六章美国关税的累积影响，2025年

第七章 人工智慧的累积影响，2025年

8. 体外膜氧合市场（依设备类型划分）

  • VA
  • VV

9. 体外膜氧合市场（依组件类型划分）

  • 套管
  • 控制器
  • 热交换器
  • 氧合设备
  • 泵浦

第十章 依病患类型分類的体外膜氧合市场

  • 成人
  • 婴儿
  • 孩子们

第十一章 体外膜氧合市场（依应用领域划分）

  • 心臟支持
    • 心源性休克
    • 心臟直视手术后
  • 体外心肺復苏
  • 呼吸支持

第十二章 体外膜氧合市场（依最终用户划分）

  • 门诊手术中心
  • 医院
  • 专科诊所

第十三章 体外膜氧合市场区域分析

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 体外膜氧合市场（依组别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国体外膜氧合市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • Getinge AB
    • Medtronic plc
    • LivaNova PLC
    • Terumo Corporation
    • Fresenius Medical Care
    • Hemovent NV
    • Spectrum Medical (UK) Limited
    • B. Braun Melsungen AG
    • Baxter International Inc.
    • Abiomed, Inc.
    • Abbott Laboratories
    • MicroPort Scientific Corporation
    • Nipro Corporation
    • OriGen Biomedical, Inc.
    • CytoSorbents Corporation
    • Senko Medical Instrument Mfg. Co., Ltd.
    • Braile Biomedica
    • Spectrum Medical Ltd.
    • Inspira Technologies OXY BHN Ltd.
    • Eurosets Srl
Product Code: MRR-03607F65CC95

The Extracorporeal Membrane Oxygenation Machine Market is projected to grow by USD 840.14 million at a CAGR of 5.40% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 551.19 million
Estimated Year [2025] USD 579.25 million
Forecast Year [2032] USD 840.14 million
CAGR (%) 5.40%

An authoritative orientation to extracorporeal membrane oxygenation as an established advanced support modality reshaping critical care pathways and procurement priorities

Extracorporeal membrane oxygenation has transitioned from a niche salvage therapy to an integral option within advanced critical care pathways, driven by incremental clinical acceptance and steady improvements in device engineering. Clinicians now view extracorporeal support as a bridge therapy that can stabilize patients through acute respiratory or cardiac crises while definitive therapies or organ recovery are pursued. Consequently, health systems and clinical teams are adapting protocols, assembling multidisciplinary ECMO teams, and investing in training and simulation to ensure safe deployment and weaning.

Technology innovators have reduced device complexity and improved circuit biocompatibility, which has increased the feasibility of deployment outside of traditional intensive care units. At the same time, regulatory scrutiny and reimbursement dynamics create both constraints and opportunities for wider adoption. As a result, stakeholders across procurement, clinical leadership, and device manufacturing are recalibrating priorities to balance clinical efficacy, operational readiness, and procurement flexibility. This introduction frames ECMO as a rapidly maturing clinical option with significant implications for care pathways, supplier relationships, and hospital resource planning.

How technological innovation combined with operational redesign and regionalized care networks is transforming extracorporeal therapy delivery and supplier relationships

The landscape for extracorporeal membrane oxygenation is being reshaped by several converging shifts that extend beyond device upgrades to influence clinical workflows, supply chains, and service models. Advances in pump technology, oxygenator efficiency, and surface coatings have reduced hemolysis and thrombotic complications, enabling longer and safer runs. Concurrently, the rise of dual-lumen cannulation strategies and percutaneous approaches has shortened deployment times and increased the portability of support, allowing for more rapid initiation in emergency and retrieval settings.

Operationally, hospitals are embedding ECMO into cardiothoracic and pulmonary care pathways, increasing routine training and simulation to ensure readiness for extracorporeal cardiopulmonary resuscitation scenarios. Telemedicine and remote monitoring tools are extending specialist oversight to smaller centers, enabling regionalized support networks and more efficient utilization of centralized expertise. On the commercial side, manufacturers are integrating digital diagnostics, plug-and-play disposables, and service contracts that emphasize uptime and lifecycle management. Taken together, these transformative forces are pushing ECMO toward greater clinical accessibility, lower procedural risk, and tighter alignment between device performance and operational workflows.

Supply chain resilience and procurement agility arising from tariff shifts in 2025 that forced reevaluation of sourcing strategies and component localization for extracorporeal systems

United States tariff changes in 2025 have introduced new dynamics for device sourcing, component procurement, and supply-chain resilience for extracorporeal membrane oxygenation systems. Import duties on select medical components and subassemblies have elevated the importance of procurement strategy, prompting device manufacturers and hospitals to reevaluate supplier footprints, component localization, and inventory policies. In response, some manufacturers accelerated qualification of alternative suppliers and secured diversified logistics channels to mitigate exposure to single-country sourcing.

These tariff-induced cost pressures encouraged a parallel emphasis on design for supply chain resilience, including modular system architectures that allow substitution of locally available components without altering clinical performance. Health systems assessed total landed cost across capital acquisition, consumables, and service contracts and increasingly considered multi-year agreements to stabilize pricing and availability. Furthermore, the tariffs stimulated dialogue between manufacturers and regulatory bodies to expedite domestic production approvals where feasible, and they reinforced the case for strategic stockpiles of critical disposables in regional centers of excellence. Ultimately, the 2025 tariff environment emphasized the need for agility in procurement and close collaboration across the clinical, regulatory, and supply-chain functions.

Segmentation-driven insights revealing how device type, component specialization, patient cohorts, clinical applications, and end-user settings shape strategic priorities

Segmentation analysis reveals differentiated dynamics across device types, components, patient cohorts, clinical applications, and end-user settings that collectively inform product strategy and go-to-market approaches. Based on device type, the field delineates between Veno Arterial systems optimized for cardiac support and Veno Venous systems tailored to respiratory support and extracorporeal oxygenation. Based on component type, the ecosystem comprises cannula, controllers, heat exchangers, oxygenators, and pumps, each carrying distinct engineering challenges and aftermarket considerations. Based on patient type, clinical requirements diverge among adults, infants, and pediatric patients, necessitating size-specific cannulation techniques, flow profiles, and monitoring capabilities.

Based on application, clinical deployment spans cardiac support, extracorporeal cardiopulmonary resuscitation, and respiratory support, with cardiac support further subdividing into cardiogenic shock and post cardiotomy interventions that demand rapid initiation and hemodynamic precision. Based on end user, adoption patterns vary across ambulatory surgical centers, hospitals, and specialty clinics, with hospitals remaining the primary locus for high-acuity cases while specialty clinics and select ambulatory settings expand capabilities for pre- and post-procedural care. Understanding these segmentation axes clarifies product development priorities, clinical training needs, and differentiated service models that manufacturers and providers must tailor to optimize both clinical outcomes and operational efficiency.

Regional strategic contrasts and collaborative opportunities that explain adoption patterns, regulatory influences, and supply choices across major global healthcare regions

Regional dynamics shape clinical adoption, regulatory pathways, and supply-chain choices across the Americas, Europe, Middle East & Africa, and Asia-Pacific, creating distinct strategic landscapes for stakeholders. In the Americas, established tertiary centers and integrated health systems have expanded extracorporeal programs, emphasizing protocol standardization, centralized training, and cross-institutional retrieval services. Reimbursement frameworks and regional centers of excellence have supported concentrated high-acuity capability while driving discussions about equitable geographic access and capacity building in smaller markets.

In Europe, Middle East & Africa, regulatory harmonization efforts and national procurement practices influence adoption cadence, with leading academic hospitals driving clinical guidelines and smaller health systems exploring partnerships or regional hubs. Training programs and mobile retrieval teams are important enablers in geographically dispersed regions. In the Asia-Pacific, rapid hospital expansion, growing critical care capacity, and targeted investments in advanced therapies have accelerated interest in extracorporeal systems, though variability in regulatory timelines and local manufacturing capabilities affects how global suppliers structure commercial entry and aftermarket support. Across all regions, cross-border collaboration on clinical registries and outcome benchmarks is increasingly shaping best practices and supplier selection criteria.

How integrated system providers and component specialists are competing on clinical performance, aftermarket service, and digital-enabled support to win long-term partnerships

Competitive dynamics among established manufacturers and specialized component suppliers are defined by a race to combine clinical performance with service excellence, consumable availability, and digital connectivity. Established system providers focus on delivering integrated platforms that minimize setup time, reduce complication risk, and offer predictable lifecycle costs through bundled service agreements. Component specialists concentrate on innovations in cannula design, oxygenator efficiency, and pump mechanics to offer performance advantages that can be licensed or incorporated into broader systems.

Across the value chain, aftermarket service and training have become differentiators, with suppliers offering simulation-based programs, remote diagnostics, and rapid-response field service to maintain clinical readiness. Partnerships between device makers and hospital networks are increasingly common, facilitating co-development of protocols, registry participation, and joint training curricula. Regulatory approvals and post-market surveillance activities favor manufacturers that maintain transparent quality systems and demonstrate sustained clinical outcomes. As capital cycles tighten, procurement teams weigh not only device performance but also supplier stability, spare-parts logistics, and the ability to support regional training and clinical governance.

Actionable strategic playbook for manufacturers and providers to strengthen design modularity, clinical training, supply resilience, and digital services for extracorporeal systems

Industry leaders should adopt a coordinated strategy that aligns product design, clinical engagement, and supply-chain resilience to capitalize on the maturation of extracorporeal therapies. Prioritize modular architectures that enable rapid substitution of components and facilitate upgrades without requiring full system replacement, thereby lowering total cost of ownership and improving procurement flexibility. Invest in clinical education programs and simulation centers to shorten the learning curve for new teams and to standardize protocols that reduce variability in outcomes.

Strengthen supplier diversification and nearshoring where feasible to mitigate tariff and logistics risk while negotiating multi-year consumable agreements to improve predictability for health systems. Expand digital capabilities to provide remote monitoring, predictive maintenance, and analytics that materially reduce downtime and support outcome benchmarking. Finally, cultivate transparent partnerships with leading clinical centers to generate real-world evidence and inform guideline development, which in turn will support broader adoption and reimbursement negotiations. These actions, carried out in parallel, will position companies and providers to deliver reliable extracorporeal care at scale while containing risk and demonstrating sustained clinical value.

A transparent, multi-source research approach combining clinician interviews, supplier engagement, regulatory review, and technical assessments to validate practical insights

This research integrates primary engagement with clinical and supply-chain stakeholders and a structured review of regulatory and technical literature to ensure an evidence-based perspective. Primary inputs included interviews with intensivists, cardiothoracic surgeons, perfusionists, procurement leaders, and senior device engineers to capture clinical practice variability, device performance expectations, and procurement constraints. Supplier discussions focused on manufacturing localization, component sourcing strategies, and aftermarket service models. Secondary sources encompassed peer-reviewed clinical studies, device labeling and regulatory filings, technical whitepapers, and publicly available hospital procurement guidelines to triangulate clinical outcomes and device feature sets.

Analytical techniques combined thematic synthesis of qualitative interviews with supply-chain mapping and technology readiness assessments to identify risk nodes and adoption enablers. Limitations include variability in institutional practice patterns and evolving regulatory decisions that can alter adoption timelines. Where possible, findings were validated across multiple stakeholder types to reduce single-source bias. The methodology emphasizes transparency and traceability so that decision-makers can align the research insights with their internal data and operational realities.

Integrated outlook on extracorporeal therapies emphasizing systems-level planning, clinician training, and supply resilience to sustain clinical impact

Extracorporeal membrane oxygenation has reached a strategic inflection point where technological maturity and clinical integration are converging to make it a practical element of modern critical care portfolios. Advances in device safety, coupled with operational innovations such as regionalized specialist networks and digital monitoring, have expanded clinical opportunities while exposing the importance of supply-chain resilience and targeted training. Stakeholders who proactively address procurement flexibility, service and training partnerships, and component localization will be best positioned to translate clinical possibility into reliable, repeatable outcomes across care settings.

Looking ahead, the most successful organizations will be those that treat extracorporeal therapy as a systems challenge rather than a single-device purchase, coupling product innovation with robust clinician education, lifecycle service offerings, and adaptive supply strategies. This integrated approach will be essential to sustain high-quality patient outcomes while managing capital and operational demands in an environment of evolving regulation and global trade dynamics.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence algorithms for real-time ECMO circuit parameter optimization
  • 5.2. Emergence of portable and transportable ECMO systems enabling point-of-care lifesaving interventions
  • 5.3. Development of biocompatible polymer coatings to reduce thrombosis in prolonged ECMO support applications
  • 5.4. Expansion of venoarterial ECMO utilization in adult cardiogenic shock management and mobile ECMO teams
  • 5.5. Advancements in low-resistance hollow fiber oxygenators for improved neonatal and pediatric ECMO outcomes
  • 5.6. Regulatory approvals driving adoption of miniaturized extracorporeal life support devices in ambulatory care
  • 5.7. Collaborations between medical device and software firms for integrated ECMO digital monitoring platforms

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Extracorporeal Membrane Oxygenation Machine Market, by Device Type

  • 8.1. Veno Arterial
  • 8.2. Veno Venous

9. Extracorporeal Membrane Oxygenation Machine Market, by Component Type

  • 9.1. Cannula
  • 9.2. Controllers
  • 9.3. Heat Exchangers
  • 9.4. Oxygenators
  • 9.5. Pumps

10. Extracorporeal Membrane Oxygenation Machine Market, by Patient Type

  • 10.1. Adults
  • 10.2. Infants
  • 10.3. Pediatric

11. Extracorporeal Membrane Oxygenation Machine Market, by Application

  • 11.1. Cardiac Support
    • 11.1.1. Cardiogenic Shock
    • 11.1.2. Post Cardiotomy
  • 11.2. Extracorporeal Cardiopulmonary Resuscitation
  • 11.3. Respiratory Support

12. Extracorporeal Membrane Oxygenation Machine Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals
  • 12.3. Specialty Clinics

13. Extracorporeal Membrane Oxygenation Machine Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Extracorporeal Membrane Oxygenation Machine Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Extracorporeal Membrane Oxygenation Machine Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Getinge AB
    • 16.3.2. Medtronic plc
    • 16.3.3. LivaNova PLC
    • 16.3.4. Terumo Corporation
    • 16.3.5. Fresenius Medical Care
    • 16.3.6. Hemovent N.V.
    • 16.3.7. Spectrum Medical (UK) Limited
    • 16.3.8. B. Braun Melsungen AG
    • 16.3.9. Baxter International Inc.
    • 16.3.10. Abiomed, Inc.
    • 16.3.11. Abbott Laboratories
    • 16.3.12. MicroPort Scientific Corporation
    • 16.3.13. Nipro Corporation
    • 16.3.14. OriGen Biomedical, Inc.
    • 16.3.15. CytoSorbents Corporation
    • 16.3.16. Senko Medical Instrument Mfg. Co., Ltd.
    • 16.3.17. Braile Biomedica
    • 16.3.18. Spectrum Medical Ltd.
    • 16.3.19. Inspira Technologies OXY B.H.N. Ltd.
    • 16.3.20. Eurosets S.r.l.

LIST OF FIGURES

  • FIGURE 1. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENO ARTERIAL, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENO ARTERIAL, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENO ARTERIAL, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENO ARTERIAL, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENO ARTERIAL, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENO ARTERIAL, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENO VENOUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENO VENOUS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENO VENOUS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENO VENOUS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENO VENOUS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY VENO VENOUS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CANNULA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CANNULA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CANNULA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CANNULA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CANNULA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CANNULA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CONTROLLERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CONTROLLERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CONTROLLERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CONTROLLERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CONTROLLERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CONTROLLERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HEAT EXCHANGERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HEAT EXCHANGERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HEAT EXCHANGERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HEAT EXCHANGERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HEAT EXCHANGERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HEAT EXCHANGERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY OXYGENATORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY OXYGENATORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY OXYGENATORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY OXYGENATORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY OXYGENATORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY OXYGENATORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PUMPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PUMPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PUMPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PUMPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PUMPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PUMPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ADULTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ADULTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ADULTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ADULTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ADULTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY ADULTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY INFANTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY INFANTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY INFANTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY INFANTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY INFANTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY INFANTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIOGENIC SHOCK, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIOGENIC SHOCK, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIOGENIC SHOCK, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIOGENIC SHOCK, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIOGENIC SHOCK, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIOGENIC SHOCK, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY POST CARDIOTOMY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY POST CARDIOTOMY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY POST CARDIOTOMY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY POST CARDIOTOMY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY POST CARDIOTOMY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY POST CARDIOTOMY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY RESPIRATORY SUPPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY RESPIRATORY SUPPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY RESPIRATORY SUPPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY RESPIRATORY SUPPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY RESPIRATORY SUPPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY RESPIRATORY SUPPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 129. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 130. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 131. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 132. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 133. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 144. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 148. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 150. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 152. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 158. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 162. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 164. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 166. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 204. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 208. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 211. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 212. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 213. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 214. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 215. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 218. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 219. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 220. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 221. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 222. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 223. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 224. AFRICA EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 228. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 229. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 230. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 244. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 245. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 249. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 250. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 251. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 252. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 253. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 254. ASEAN EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 255. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY DEVICE TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY COMPONENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2018-2024 (USD MILLION)
  • TABLE 262. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY PATIENT TYPE, 2025-2032 (USD MILLION)
  • TABLE 263. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 264. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 265. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2018-2024 (USD MILLION)
  • TABLE 266. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY CARDIAC SUPPORT, 2025-2032 (USD MILLION)
  • TABLE 267. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. GCC EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE MARKET SIZE, BY END USER, 20